These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29312595)
21. Structural Investigation of a Dimeric Variant of Pyruvate Kinase Muscle Isoform 2. Srivastava D; Razzaghi M; Henzl MT; Dey M Biochemistry; 2017 Dec; 56(50):6517-6520. PubMed ID: 29182273 [TBL] [Abstract][Full Text] [Related]
22. Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells. An S; Huang L; Miao P; Shi L; Shen M; Zhao X; Liu J; Huang G Onco Targets Ther; 2018; 11():2097-2109. PubMed ID: 29713182 [TBL] [Abstract][Full Text] [Related]
23. Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis. Zahra K; Dey T; Ashish ; Mishra SP; Pandey U Front Oncol; 2020; 10():159. PubMed ID: 32195169 [TBL] [Abstract][Full Text] [Related]
24. Mutant p53 and mTOR/PKM2 regulation in cancer cells. Dando I; Cordani M; Donadelli M IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486 [TBL] [Abstract][Full Text] [Related]
25. Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway. Hsu MC; Hung WC; Yamaguchi H; Lim SO; Liao HW; Tsai CH; Hung MC Am J Cancer Res; 2016; 6(3):628-38. PubMed ID: 27152240 [TBL] [Abstract][Full Text] [Related]
26. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells. Kumar B; Bamezai RN Mol Biol Rep; 2015 Aug; 42(8):1317-21. PubMed ID: 25840825 [TBL] [Abstract][Full Text] [Related]
27. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics. Kalaiarasan P; Subbarao N; Bamezai RN J Mol Model; 2014 Sep; 20(9):2447. PubMed ID: 25208557 [TBL] [Abstract][Full Text] [Related]
28. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture. Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370 [TBL] [Abstract][Full Text] [Related]
29. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Mazurek S Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581 [TBL] [Abstract][Full Text] [Related]
30. Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling. Hsu MC; Hung WC Mol Cancer; 2018 Feb; 17(1):35. PubMed ID: 29455645 [TBL] [Abstract][Full Text] [Related]
31. Pyruvate kinase M2 interacts with DNA damage-binding protein 2 and reduces cell survival upon UV irradiation. Xie X; Wang M; Mei J; Hu F; Ding F; Lv L Biochem Biophys Res Commun; 2015 Nov; 467(2):427-33. PubMed ID: 26410533 [TBL] [Abstract][Full Text] [Related]
32. PKM2, a Central Point of Regulation in Cancer Metabolism. Wong N; De Melo J; Tang D Int J Cell Biol; 2013; 2013():242513. PubMed ID: 23476652 [TBL] [Abstract][Full Text] [Related]
33. Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation. Liu YZ; Xu MY; Dai XY; Yan L; Li L; Zhu RZ; Ren LJ; Zhang JQ; Zhang XF; Li JF; Tian YJ; Shi WJ; Liu YQ; Jiang CL; Zhu JB; Chen JK Front Pharmacol; 2021; 12():765790. PubMed ID: 34733164 [TBL] [Abstract][Full Text] [Related]
34. SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions. Bhardwaj A; Das S Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E538-47. PubMed ID: 26787900 [TBL] [Abstract][Full Text] [Related]
35. Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect. Wiese EK; Hitosugi T Front Cell Dev Biol; 2018; 6():79. PubMed ID: 30087897 [TBL] [Abstract][Full Text] [Related]
36. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Lee J; Kim HK; Han YM; Kim J Int J Biochem Cell Biol; 2008; 40(5):1043-54. PubMed ID: 18191611 [TBL] [Abstract][Full Text] [Related]
37. Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis. Shan S; Shi J; Yang P; Jia B; Wu H; Zhang X; Li Z J Agric Food Chem; 2017 Sep; 65(37):8136-8144. PubMed ID: 28829588 [TBL] [Abstract][Full Text] [Related]
38. Muscle-Specific Pyruvate Kinase Isoforms, Pkm1 and Pkm2, Regulate Mammalian SWI/SNF Proteins and Histone 3 Phosphorylation During Myoblast Differentiation. Olea-Flores M; Sharma T; Verdejo-Torres O; DiBartolomeo I; Thompson PR; Padilla-Benavides T; Imbalzano AN bioRxiv; 2024 Apr; ():. PubMed ID: 38645038 [TBL] [Abstract][Full Text] [Related]
39. Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase. Ning X; Qi H; Li R; Li Y; Jin Y; McNutt MA; Liu J; Yin Y Eur J Med Chem; 2017 Sep; 138():343-352. PubMed ID: 28688274 [TBL] [Abstract][Full Text] [Related]
40. Pyruvate kinase type M2: a crossroad in the tumor metabolome. Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]